Marking a vital milestone for Vertex and Charles River

FHS
January 9, 2024
12:58 pm

Charles River’s Memphis facility approved to manufacture Vertex’s CASGEVY™ therapy, the world’s first gene-edited therapy targeting severe sickle cell disease

Advances in mitochondria-targeted medicine for TBI in military settings

During the 15th Annual Meeting of the World Mitochondria Society (WMS), taking place in Berlin, Germany, groundbreaking research on mitochondria-targeted medicine in military settings will

September 27, 2024

Rectangle Health Launches Technology Partnership Program

What You Should Know: – Rectangle Health, a leading healthcare technology company, today announced the launch of its Technology Partnership Program (TPP). This program aims

March 18, 2024

MarketingRx roundup: Pfizer leads pharma ad wave at Golden Globes; Evoke rebrands and streamlines

Pfizer turned up on the red carpet Sunday as sponsor of the Golden Globe Awards, but was just one of 10 pharma marketers on the

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.